Literature DB >> 28371405

Epidemiology and clinical characteristics of patients hospitalized for ocular trauma in South-Central China.

Wanpeng Wang1, Yalan Zhou1, Jun Zeng1, Meng Shi1, Baihua Chen1.   

Abstract

PURPOSE: Ocular trauma is a major cause of visual loss, but little is known about its epidemiology and clinical characteristics in China. The aim of this study was to determine the prevalence and clinical characteristics of ocular trauma and assess prognostic factors in Changsha, Hunan, located in South-Central China.
METHODS: A retrospective case series (ICD codes: S05) study of ocular trauma in patients was performed at the Second Xiangya Hospital, Central South University, from 1 January 2010 to 31 December 2014. Demographic information, injury causes, ocular trauma types and initial and final visual acuity (VA) were recorded and analysed. The ocular trauma score (OTS) was calculated to assess the extent of the eye injury, prognosis and factors associated with visual impairment. All patient data were collected from the medical records system.
RESULTS: Of the 2009 patients presenting during this 5-year period, 1695 (84.4%) were males and 314 (15.6%) were females. The average age of all patients was 37.0 ± 19.3 years (range from 1 to 87 years). The age distribution showed a peak in the ocular trauma population in the 41- to 50-year age group (24%, n = 482), followed by the 51- to 60-year age group (16.9%, n = 339). Overall, open-globe injuries had a higher frequency (70.7%, n = 1420) than closed-globe injuries (28.6%, n = 575) and thermal/chemical injuries (0.7%, n = 14). Of the open-globe injuries, corneal penetration was the most common injury (32.2%, n = 646) followed by rupture (21.5%, n = 432) and an intraocular foreign body (16.2%, n = 325). Overall, the most frequent ocular trauma setting was the workplace (39.6%, n = 795), followed by the home (28.4%, n = 570), and the most frequent activity was ironwork. Firecracker- and firework-associated ocular trauma was significantly higher during the months of January and February than during other months (50.0%, n = 112, p < 0.001). In patients under 18 years, the most frequently occurring injury was open globe (84.5%, n = 349) with corneal penetration (59.3%, n = 245). Overall, an operation was performed in 1865 (92.8%) cases, and 144 cases (7.2%) were treated conservatively with medication. The average OTS score was 47.1 ± 19.5. The visual prognosis was closely correlated with the initial VA (r = 0.570, p = 0.000) and the OTS score (r = 0.603, p = 0.000).
CONCLUSION: This study describes the epidemiology and clinical characteristics of patients hospitalized for ocular trauma in South-Central China. Notably, a high rate of firework-related ocular trauma occurred during the months adjacent to the Chinese New Year festival. Specific injury prevention strategies, such as the use of protective eyewear, need to target the workplace to reduce the incidence and severity of ocular trauma.
© 2017 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990OTSzzm321990; South-Central China; clinical characteristics; epidemiology; ocular trauma

Mesh:

Year:  2017        PMID: 28371405     DOI: 10.1111/aos.13438

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  15 in total

1.  Clinical characteristics of patients hospitalized for ocular chemical injuries in Shanghai from 2012 to 2017.

Authors:  Tao Li; Bo Jiang; Xiaodong Zhou
Journal:  Int Ophthalmol       Date:  2020-01-09       Impact factor: 2.031

2.  Occult suprachoroidal foreign bodies: a 3-case report.

Authors:  Hu-Ping Song; Rong-Le Zhou; Zhao-Liang Zhu; Tao Chen; Jian-Zhou Wang
Journal:  Int J Ophthalmol       Date:  2022-07-18       Impact factor: 1.645

3.  Malpractice Litigation in Ophthalmic Trauma.

Authors:  Stephanie B Engelhard; Sherveen S Salek; Grant A Justin; Austin J Sim; Fasika A Woreta; Ashvini K Reddy
Journal:  Clin Ophthalmol       Date:  2020-07-12

4.  Epidemiology of outpatient and inpatient eye injury in Taiwan: 2000, 2005, 2010, and 2015.

Authors:  Jiahn-Shing Lee; Wei-Min Chen; Lu-Hsiang Huang; Chia-Chi Chung; Kuang-Hui Yu; Chang-Fu Kuo; Lai-Chu See
Journal:  PLoS One       Date:  2020-07-01       Impact factor: 3.240

5.  Intraocular foreign body injury in children: clinical characteristics and factors associated with endophthalmitis.

Authors:  Yao Yang; Chengcheng Yang; Ruijuan Zhao; Lixia Lin; Fang Duan; Bingsheng Lou; Zhaohui Yuan; Xiaofeng Lin
Journal:  Br J Ophthalmol       Date:  2019-09-25       Impact factor: 4.638

6.  Epidemiology of pediatric eye injuries requiring hospitalization in rural areas of Wenzhou and Changsha, China: a 10-year retrospective study.

Authors:  Chunyan Li; Yaoyao Lin; Haishao Xiao; Huan Lin; Yanyan Chen; Minhui Dai
Journal:  BMC Ophthalmol       Date:  2020-03-14       Impact factor: 2.209

7.  Epidemiology, Clinical Characteristics, and Visual Outcomes of Patients with Intraocular Foreign Bodies in Southwest China: A 10-Year Review.

Authors:  Tiancong Chang; Yun Zhang; Ling Liu; Keren Zhang; Xinyu Zhang; Miao Wang; Yue Zeng; Meixia Zhang
Journal:  Ophthalmic Res       Date:  2020-11-13       Impact factor: 2.892

8.  Comorbidities of scars in China: a national study based on hospitalized cases.

Authors:  Weishi Kong; Yongqiang Xiao; Baoli Wang; Zhe Zhu; Lunyang Hu; Hongtai Tang; Kangan Wang; He Fang; Ying Shi; Jianyan Long; Lanxia Gan; Haibo Wang; Yu Sun; Zhaofan Xia
Journal:  Burns Trauma       Date:  2021-06-10

9.  The Epidemiological Profile of Open Globe Injuries and Prognostic Factors in a Tertiary Care Centre.

Authors:  Hui Ruan Ng; Shew Fei Chee; Khai-Siang Chai; Mei Fong Chong; Mushawiahti Mustapha
Journal:  Cureus       Date:  2021-06-22

10.  Clinical Characteristics and Visual Outcomes of Patients Hospitalized for Ocular Trauma in Shandong Province, China.

Authors:  Fangnan Duan; Xiunian Chen; Sai Zhang; Xiaolin Qi; Weiyun Shi; Hua Gao
Journal:  J Ophthalmol       Date:  2020-04-15       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.